Lucas was just six years old when the doctors in Belgium handed his parents a sentence: terminal brainstem cancer. It’s called DIPG—a diffuse intrinsic pontine glioma—and it’s a monster. Growing in the very center of the brainstem that controls your breathing and heartbeat, it cannot be operated on. For nine children in ten, it kills within two years.
But Lucas was a one-in-a-million child in more ways than one.
His desperate parents took him to Gustave Roussy, the renowned cancer center near Paris, to join a groundbreaking clinical trial called BIOMEDE. Every child had their tumor biopsied, then they all drew a lot for one of three drugs. Lucas’s lot was for everolimus.
This is the first thing you don’t know: Everolimus was a drug licensed for kidney and breast cancer. It had never been tried on DIPG.
A MIRACLE AT THE CELLULAR LEVEL
Under the care of oncologist Jacques Grill, Lucas started the daily tablet. The entire medical team held their breath. Against all known models, they watched—scan after scan—as Lucas’s tumor didn’t just shrink; it vanished.
This is the second thing you don’t know: The scans were clear. Nobody dared to tell his family to stop the drug, terrified the monster would return. But after months of this, Lucas made a shocking revelation that left his doctors speechless.
He told them he had stopped taking the everolimus months earlier. He just… stopped.
THE SCIENCE BEHIND THE MIRACLE
The entire medical community was stunned. Not only had a kidney cancer drug worked on an incurable brain cancer, but the cure had lasted even after the treatment stopped.
This is the final thing you don’t know: The truth was hiding in his DNA. Scientists now believe that Lucas’s tumor carried an extremely rare genetic mutation. This rare profile, perhaps unique to him, made his cancer cells unusually, exquisitely sensitive to everolimus. While seven other children in the trial went into remission, only his tumor completely vanished.
Everolimus is not a general cure for DIPG. But for Lucas, it was a precise key for a precise lock. While this extraordinary case offers invaluable data and fuels ongoing research for targeted therapies, it was a miracle born of science, a rare mutation, and a child’s unauthorized decision.
It is a story of hope and a profound reminder of the scientific frontier that medicine is still charting. While a recent comment on the viral post tragically reports a relapse, the incredible initial outcome of Lucas’s case remains a historical breakthrough that will forever change how doctors understand this devastating disease.